Reports that an influential group of advisers plans to recommend against routine screening of prostate cancer has drawn criticism from health groups worried the move will increase cancer deaths in men - despite much research which has shown the total uselessness of PSA testing.
The New York Times on Thursday reported that the U.S. Preventive Services Task Force is thinking of recommending against use of the prostate-specific antigen or PSA test.
The task force, an independent panel appointed by the federal government, plans to give a common blood test known as the PSA test a rating of "D," suggesting there is moderate or high certainty that the test has no net benefit or that the harms outweigh the benefits.
Current recommendations say there is insufficient evidence to support the use of the test.
Read more here:
Groups defend need for prostate screening
